Trial Profile
Maintenance therapy with Everolimus in patients with tuberous sclerosis successfully treated for subependymal giant cell astrocytoma - EMINENTS (Everolimus MaINtENance Therapy in SEGA)
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Tuberous sclerosis
- Focus Therapeutic Use
- Acronyms EMINENTS
- 15 Sep 2016 New trial record